Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros








Base de dados
Tipo de estudo
Intervalo de ano de publicação
1.
Zhongguo Shi Yan Xue Ye Xue Za Zhi ; 32(2): 476-482, 2024 Apr.
Artigo em Chinês | MEDLINE | ID: mdl-38660855

RESUMO

OBJECTIVE: To study the reversal effect of NVP-BEZ235 on doxorubicin resistance in Burkitt lymphoma RAJI cell line. METHODS: The doxorubicin-resistant cell line was induced by treating RAJI cells with a concentration gradient of doxorubicin. The levels of Pgp, p-AKT, and p-mTOR in cells were detected by Western blot. Cell viability was detected by MTT assay. IC50 was computed by SPSS. RESULTS: The doxorubicin-resistant Burkitt lymphoma cell line, RAJI/DOX, was established successfully. The expression of Pgp and the phosphorylation levels of AKT and mTOR in RAJI/DOX cell line were both higher than those in RAJI cell line. NVP-BEZ235 downregulated the phosphorylation levels of AKT and mTOR in RAJI/DOX cell line. NVP-BEZ235 inhibited the proliferation of RAJI/DOX cell line, and the effect was obvious when it was cooperated with doxorubicin. CONCLUSION: The constitutive activation of PI3K/AKT/mTOR pathway of RAJI/DOX cell line was more serious than RAJI cell line. NVP-BEZ235 reversed doxorubicin resistance of RAJI/DOX cell line by inhibiting the PI3K/AKT/mTOR signal pathway.


Assuntos
Linfoma de Burkitt , Proliferação de Células , Doxorrubicina , Resistencia a Medicamentos Antineoplásicos , Imidazóis , Proteínas Proto-Oncogênicas c-akt , Quinolinas , Serina-Treonina Quinases TOR , Humanos , Doxorrubicina/farmacologia , Linhagem Celular Tumoral , Proteínas Proto-Oncogênicas c-akt/metabolismo , Quinolinas/farmacologia , Serina-Treonina Quinases TOR/metabolismo , Proliferação de Células/efeitos dos fármacos , Imidazóis/farmacologia , Fosfatidilinositol 3-Quinases/metabolismo , Transdução de Sinais , Sobrevivência Celular/efeitos dos fármacos , Fosforilação
2.
Parasit Vectors ; 8: 214, 2015 Apr 10.
Artigo em Inglês | MEDLINE | ID: mdl-25889417

RESUMO

BACKGROUND: Toxoplasma gondii is an obligate, intracellular protozoan that infects almost all warm-blooded animals, including humans, domesticated and wild animals. Recent studies of Toxoplasma gondii isolates from animals in different regions of China have shown a limited genetic diversity with the dominance of the ToxoDB PCR-RFLP genotype #9 named as "Chinese 1". However, there is not much published information regarding its prevalence in domestic animals from Guizhou province, a subtropical region in Southwest China. The objectives of this study were to determine seroprevalence and genetic diversity of T .gondii in pigs, dogs and cats in Guizhou province, Southwest China. FINDINGS: The anti-T. gondii IgG were detected in 70.0%(49/70) pigs, 20.56%(22/107) dogs and 63.16(12/19) cats. The anti-T. gondii IgM were found in 0.93%(1/107) dogs, 21.53%(4/19) cats, but not in pigs. In addition, the toxoplasma circulating antigen (CAG) were detected in 16.9%18/70)pigs, 13.1% (14/107) dogs and 10.5%(2/19) cats. The T. gondii DNA were detected in 31.5%(22/70) pigs, 3.7%(4/107) dogs and 52.63%(10/19) cats. Five T. gondii isolates were obtained(3 from pigs and 2 from cats). The genotype of these five isolates belonged to the predominant genotype "Chinese 1". CONCLUSIONS: The high prevalence of T. gondii infection in pigs,cats and dogs indicated that the T. gondii infection is common in Guizhou province. Additionally, the T. gondii genotype "Chinese 1" was dominant in Southwest China.


Assuntos
Doenças do Gato/epidemiologia , Doenças do Cão/epidemiologia , Genótipo , Doenças dos Suínos/epidemiologia , Toxoplasma/isolamento & purificação , Toxoplasmose Animal/epidemiologia , Animais , Doenças do Gato/parasitologia , Gatos , China/epidemiologia , Doenças do Cão/parasitologia , Cães , Estudos Soroepidemiológicos , Suínos , Doenças dos Suínos/parasitologia , Toxoplasma/genética , Toxoplasma/imunologia , Toxoplasmose Animal/parasitologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA